Abdominal Morphologic Changes in MRI during Gastric Balloon Therapy

Obes Facts. 2022;15(5):703-710. doi: 10.1159/000526444. Epub 2022 Aug 16.

Abstract

Introduction: Adiposity and excessive weight are on the rise in western industrialized countries. In cases where conservative measures fail and surgical interventions are not (yet) desired, gastric balloon therapy has proven to be a safe and reversible endoscopic method.

Methods: Aside from weight progression under gastric balloon therapy and by using MRI, our research paper describes the behavior of different abdominal body fat compartments at the beginning and at the end of the gastric balloon therapy. Additionally, the volume of the left liver lobe as well as the fill volume and performance of the gastric balloon were analyzed over the duration of treatment. For assessing potential impacts of weight reduction on the muscle mass, we determined the area of the m. psoas on a comparable cross-sectional area at the beginning and at the end of the therapy.

Results: We were able to verify a significant reduction of the layer of subcutaneous fat, adipose capsule of the kidney, and intra-abdominal fatty tissue during the therapy. The volume of the left liver lobe was shrinking in addition to a muscle loss during the balloon therapy. The volume of the gastric balloon remained stable (not hyperinflation). There were variable gas bubbles in the gastric balloon.

Conclusion: The gastric balloon is a temporary and successful option for weight reduction by reducing body fat, liver volume, but also muscle mass.

Keywords: Fatty tissue; Gastric balloon; Liver volume; Obesity; Sarcopenic adiposity.

MeSH terms

  • Abdominal Fat
  • Gastric Balloon*
  • Humans
  • Intra-Abdominal Fat
  • Magnetic Resonance Imaging
  • Obesity / therapy
  • Weight Loss

Grants and funding

This research did not receive grants from any funding agency in the public, commercial, or not-for-profit sectors.